Cargando…
Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 2 recurrent glioblastoma
BACKGROUND: There exists no consensus standard of treatment for patients with recurrent glioblastoma (GB). Here we used a network meta-analysis on treatments from randomized control trials (RCTs) to assess the effect on overall survival (OS) and progression-free survival (PFS) to determine if any co...
Autores principales: | Taslimi, Shervin, Ye, Vincent C, Wen, Patrick Y, Zadeh, Gelareh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134527/ https://www.ncbi.nlm.nih.gov/pubmed/34042101 http://dx.doi.org/10.1093/noajnl/vdab029 |
Ejemplares similares
-
Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 1 newly diagnosed disease
por: Taslimi, Shervin, et al.
Publicado: (2021) -
Erratum to: Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 1 newly diagnosed disease
por: Taslimi, Shervin, et al.
Publicado: (2021) -
Predictors of survival in elderly patients undergoing surgery for glioblastoma
por: Voisin, Mathew R, et al.
Publicado: (2021) -
A microRNA Link to Glioblastoma Heterogeneity
por: Singh, Sanjay K., et al.
Publicado: (2012) -
Contemporary RNA Therapeutics for Glioblastoma
por: Melnick, Kaitlyn, et al.
Publicado: (2021)